US Patent Issued to BREXOGEN on April 7 for "Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,303, issued on April 7, was assigned to BREXOGEN INC. (Seoul, South Korea).

"Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis" was invented by Sue Kim (Seoul, South Korea), Seulki Lee (Gyeonggi-do, South Korea) and Jimin Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for prevention or treatment of non-alcoholic steatohepatitis, the composition comprising, as an active ingredient, exosomes isolated from induced pluripotent stem cell-derive...